Ata Garajei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ata Garajei has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Abdolamir Allameh
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
4 shared publications Ali A. Kheradmand
4 shared publications- Hady Mohammadi
Department of Oral and Maxillofacial Surgery, Fellowship in Maxillofacial Trauma, Health Services, Kurdistan University of Medical Sciences, Sanandaj 6617713446, Iran
4 shared publications - Masoud Sadeghi
Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
4 shared publications Maziar Motiee-Langroudi
Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
4 shared publications- Mohammad Hosein Kalantar Motamedi
Oral and Maxillofacial Surgery, Trauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
4 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (11) , 1376
A Modified Corticocancellous Shell Technique (Kamali Technique) for Horizontal Alveolar Ridge Augmentation
Background: The shell technique is a well-recognized method for alveolar ridge augmentation; however, conventional protocols are often technically demanding, requiring substantial autogenous bone harvesting and precise fixation of thin cortical shells, which is a step associated with risks of graft fracture and increased operative time. Objective: The Kamali technique, described in this case report, represents a modification of the conventional shell technique that employs corticocancellous allogeneic bone blocks to provide structural support for graft containment while minimizing reliance on autogenous bone. Methods: This report describes a single patient who underwent horizontal alveolar ridge augmentation using the modified corticocancellous shell (Kamali) technique as part of routine clinical care. Clinical records, surgical documentation, clinical photographs, and preoperative and postoperative cone-beam computed tomography (CBCT) images were reviewed to describe the treatment procedure and clinical and radiographic findings. No additional intervention was performed for research purposes. The corticocancellous allogeneic block was contoured to fit the osseous defect and stabilized using fixation screws. Particulate autogenous bone harvested from an intraoral donor site was combined with a bone substitute and placed within the grafted compartment. Clinical and radiographic healing was assessed at approximately six months. Results/Clinical Observations: The corticocancellous composition of the allogeneic block provided a structural framework for particulate graft containment and space maintenance. The porous architecture of the cancellous portion appeared to facilitate graft integration and vascular ingrowth. Ridge width increased from 2.9 mm preoperatively to 8.5 mm after six months, allowing placement of a 4 × 9.5 mm implant with more than 35 Ncm primary stability. In this case, the technique allowed the use of a reduced volume of autogenous bone and was successfully applied for graft fixation and horizontal ridge augmentation. Conclusions: The Kamali technique represents a potential modification of conventional shell techniques for horizontal alveolar ridge augmentation. However, its clinical efficacy and reproducibility require further investigation through larger clinical studies and controlled trials.
- 18 November 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (11) , 1376
Open AccessA Modified Corticocancellous Shell Technique (Kamali Technique) for Horizontal Alveolar Ridge Augmentation
Background: The shell technique is a well-recognized method for alveolar ridge augmentation; however, conventional protocols are often technically demanding, requiring substantial autogenous bone harvesting and precise fixation of thin cortical shells, which is a step associated with risks of graft fracture and increased operative time. Objective: The Kamali technique, described in this case report, represents a modification of the conventional shell technique that employs corticocancellous allogeneic bone blocks to provide structural support for graft containment while minimizing reliance on autogenous bone. Methods: This report describes a single patient who underwent horizontal alveolar ridge augmentation using the modified corticocancellous shell (Kamali) technique as part of routine clinical care. Clinical records, surgical documentation, clinical photographs, and preoperative and postoperative cone-beam computed tomography (CBCT) images were reviewed to describe the treatment procedure and clinical and radiographic findings. No additional intervention was performed for research purposes. The corticocancellous allogeneic block was contoured to fit the osseous defect and stabilized using fixation screws. Particulate autogenous bone harvested from an intraoral donor site was combined with a bone substitute and placed within the grafted compartment. Clinical and radiographic healing was assessed at approximately six months. Results/Clinical Observations: The corticocancellous composition of the allogeneic block provided a structural framework for particulate graft containment and space maintenance. The porous architecture of the cancellous portion appeared to facilitate graft integration and vascular ingrowth. Ridge width increased from 2.9 mm preoperatively to 8.5 mm after six months, allowing placement of a 4 × 9.5 mm implant with more than 35 Ncm primary stability. In this case, the technique allowed the use of a reduced volume of autogenous bone and was successfully applied for graft fixation and horizontal ridge augmentation. Conclusions: The Kamali technique represents a potential modification of conventional shell techniques for horizontal alveolar ridge augmentation. However, its clinical efficacy and reproducibility require further investigation through larger clinical studies and controlled trials.
- Open Access
- 25 September 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Food intake and the risk of oral squamous cell carcinoma: a case–control study in Iran
- 25 September 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessFood intake and the risk of oral squamous cell carcinoma: a case–control study in Iran
- Open Access
- 17 September 2026
- Published by Elsevier in JPRAS Open
- Vol. 52, 496-499
Dermal sling as an alternative to palmaris longus tendon suspension in radial forearm flap lower lip reconstruction: A case report
- 17 September 2026
- Published by Elsevier in JPRAS Open
- Vol. 52, 496-499
Open AccessDermal sling as an alternative to palmaris longus tendon suspension in radial forearm flap lower lip reconstruction: A case report
- Open Access
- 29 July 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Challenging diagnostic cases of peripheral ameloblastoma: a case series
Ameloblastoma is a common neoplasm originating from the odontogenic epithelium and is known for its slow growth, local invasiveness, and benign nature. The
- 29 July 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Open AccessChallenging diagnostic cases of peripheral ameloblastoma: a case series
Ameloblastoma is a common neoplasm originating from the odontogenic epithelium and is known for its slow growth, local invasiveness, and benign nature. The
- Open Access
- 25 March 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (7) , 1244
Evaluation of the Expression Levels of miR-21-5p and miR-429 Genes in Biopsy Samples from Patients with Oral Squamous Cell Carcinoma
Introduction: MicroRNAs (miRs) are a group of endogenous, non-coding, 18-24 nucleotide length single-strand RNAs that mediate gene expression at the post-transcriptional level through mRNA degradation or translational repression. They are involved in regulating diverse cellular biological processes such as cell cycle, differentiation, and apoptosis. The deregulation of miRs affects normal biological processes, leading to malignancies, including oral squamous cell carcinoma (OSCC). This study evaluates the expression level of miR-21-5p and miR-429 genes in biopsy samples from patients with OSCC and performs a comparison with controls. Materials and Methods: In this study, tissue samples were obtained from 40 individuals (20 OSCC patients and 20 healthy controls) to determine miR-21-5p and miR-429 expression using the ΔCT method and analyzed by the Mann–Whitney test. Results: The mean age of subjects in the control and patient groups was 47.15 and 53.8 years, respectively. According to the Mann–Whitney test, significant differences were observed in miR-21-5p (p < 0.0001) and miR-429 (p = 0.0191) expression levels between the two groups (p < 0.05). Conclusions: The expression of miR-21-5p, miR-429, and combined miRNAs in the OSCC group was significantly higher compared to the control group. As a result, changes in the expression of these biomarkers in cancerous tissues could potentially be considered as a marker for the early diagnosis of OSCC.
- 25 March 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (7) , 1244
Open AccessEvaluation of the Expression Levels of miR-21-5p and miR-429 Genes in Biopsy Samples from Patients with Oral Squamous Cell Carcinoma
Introduction: MicroRNAs (miRs) are a group of endogenous, non-coding, 18-24 nucleotide length single-strand RNAs that mediate gene expression at the post-transcriptional level through mRNA degradation or translational repression. They are involved in regulating diverse cellular biological processes such as cell cycle, differentiation, and apoptosis. The deregulation of miRs affects normal biological processes, leading to malignancies, including oral squamous cell carcinoma (OSCC). This study evaluates the expression level of miR-21-5p and miR-429 genes in biopsy samples from patients with OSCC and performs a comparison with controls. Materials and Methods: In this study, tissue samples were obtained from 40 individuals (20 OSCC patients and 20 healthy controls) to determine miR-21-5p and miR-429 expression using the ΔCT method and analyzed by the Mann–Whitney test. Results: The mean age of subjects in the control and patient groups was 47.15 and 53.8 years, respectively. According to the Mann–Whitney test, significant differences were observed in miR-21-5p (p < 0.0001) and miR-429 (p = 0.0191) expression levels between the two groups (p < 0.05). Conclusions: The expression of miR-21-5p, miR-429, and combined miRNAs in the OSCC group was significantly higher compared to the control group. As a result, changes in the expression of these biomarkers in cancerous tissues could potentially be considered as a marker for the early diagnosis of OSCC.
- Open Access
Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma
Background and objective: Oral squamous cell carcinoma (OSCC) is the most common head and neck malignancy. Expression patterns of microRNAs (miRNAs) can direct us in identifying valuable biomarkers for the prognosis of different neoplasms. Inappropriate regulation of miRNAs during physiological procedures can result in malignancies including OSCC. The aim of the present study was to evaluate the expression of miR-486-3p, miR-561-5p, miR-548-3p, and miR-509-5p in tissue biopsy samples with and without OSCC. Materials and methods: This case-control study was conducted on 17 healthy and 17 OSCC tissue biopsy samples. The expression of miRNAs was assessed using quantitative real-time PCR (q-RT-PCR) after RNA extraction from normal and cancer tissues and cDNA synthesis. Results: The means of miRNA-486-3p, miR-561-5p, and miR-548-3p expression were significantly different between OSCC and control groups (p < 0.001), but there was no significant difference in means of miR-509-5p expression between OSCC and control groups (p = 0.179). Conclusions: The findings of this study revealed that the expression of miR-486-3p and miR-561-5p was significantly lower in cancer samples compared to normal tissue samples. On the other hand, miR-548-3p expression increased in the OSCC group compared to the control group.
Open AccessEvaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma
Background and objective: Oral squamous cell carcinoma (OSCC) is the most common head and neck malignancy. Expression patterns of microRNAs (miRNAs) can direct us in identifying valuable biomarkers for the prognosis of different neoplasms. Inappropriate regulation of miRNAs during physiological procedures can result in malignancies including OSCC. The aim of the present study was to evaluate the expression of miR-486-3p, miR-561-5p, miR-548-3p, and miR-509-5p in tissue biopsy samples with and without OSCC. Materials and methods: This case-control study was conducted on 17 healthy and 17 OSCC tissue biopsy samples. The expression of miRNAs was assessed using quantitative real-time PCR (q-RT-PCR) after RNA extraction from normal and cancer tissues and cDNA synthesis. Results: The means of miRNA-486-3p, miR-561-5p, and miR-548-3p expression were significantly different between OSCC and control groups (p < 0.001), but there was no significant difference in means of miR-509-5p expression between OSCC and control groups (p = 0.179). Conclusions: The findings of this study revealed that the expression of miR-486-3p and miR-561-5p was significantly lower in cancer samples compared to normal tissue samples. On the other hand, miR-548-3p expression increased in the OSCC group compared to the control group.
- Open Access
Association between Interleukin-1 Polymorphisms and Susceptibility to Dental Peri-Implant Disease: A Meta-Analysis
Background and objective: Interleukins (ILs), as important biochemical mediators, control the host response to inflammation and are associated with bone resorption. In the present meta-analysis, we investigated the association between IL−1 polymorphisms and susceptibility to dental peri-implant disease (PID). Materials and methods: We searched Web of Science, Cochrane Library, Scopus, and PubMed/Medline databases for studies published until 9 September2021, without any restrictions. We calculated the crude OR and 95% confidence intervals (CI) to estimate the associations between IL−1 polymorphisms and PID risk in the five genetic models. We further performed the subgroup analysis, sensitivity analysis, meta-regression, trial sequential analysis, and calculated the publication bias. Results: Out of 212 retrieved records, sixteen articles were used in the meta-analysis. There was no association between IL−1A (–889), IL−1B (−511), IL−1B (+3953), and IL−1RN (VNTR) polymorphisms and the risk of dental PIDs, but there was an increased risk of IL−1B (+3954) in the patients with PIDs. In addition, an association of the composite genotype of IL−1A (−889)/IL−1B (+3953) was observed with the risk of PIDs, but not for the composite genotype of IL−1A (−889)/IL−1B (+3954). The publication year, the ethnicity, sample size, and the outcome were significantly influenced pooled estimates of some genetic models. Trial sequential analysis showed the lack of sufficient sample sizes in the studies. Conclusions: Among IL−1 polymorphisms evaluated in the meta-analysis, the composite genotype of IL−1A (−889)/IL−1B (+3953) and IL−1B (+3954) were the only polymorphisms associated with the risk of PID. The T allele and CT genotype of IL−1B (+3954) polymorphism were also associated with an elevated risk of PID.
Open AccessAssociation between Interleukin-1 Polymorphisms and Susceptibility to Dental Peri-Implant Disease: A Meta-Analysis
Background and objective: Interleukins (ILs), as important biochemical mediators, control the host response to inflammation and are associated with bone resorption. In the present meta-analysis, we investigated the association between IL−1 polymorphisms and susceptibility to dental peri-implant disease (PID). Materials and methods: We searched Web of Science, Cochrane Library, Scopus, and PubMed/Medline databases for studies published until 9 September2021, without any restrictions. We calculated the crude OR and 95% confidence intervals (CI) to estimate the associations between IL−1 polymorphisms and PID risk in the five genetic models. We further performed the subgroup analysis, sensitivity analysis, meta-regression, trial sequential analysis, and calculated the publication bias. Results: Out of 212 retrieved records, sixteen articles were used in the meta-analysis. There was no association between IL−1A (–889), IL−1B (−511), IL−1B (+3953), and IL−1RN (VNTR) polymorphisms and the risk of dental PIDs, but there was an increased risk of IL−1B (+3954) in the patients with PIDs. In addition, an association of the composite genotype of IL−1A (−889)/IL−1B (+3953) was observed with the risk of PIDs, but not for the composite genotype of IL−1A (−889)/IL−1B (+3954). The publication year, the ethnicity, sample size, and the outcome were significantly influenced pooled estimates of some genetic models. Trial sequential analysis showed the lack of sufficient sample sizes in the studies. Conclusions: Among IL−1 polymorphisms evaluated in the meta-analysis, the composite genotype of IL−1A (−889)/IL−1B (+3953) and IL−1B (+3954) were the only polymorphisms associated with the risk of PID. The T allele and CT genotype of IL−1B (+3954) polymorphism were also associated with an elevated risk of PID.
- Open Access
Association of N-acetyltransferases 1 and 2 Polymorphisms with Susceptibility to Head and Neck Cancers—A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis
Background and objective:N-acetyltransferases 1 and 2 (NAT1 and NAT2) genes have polymorphisms in accordance with slow and rapid acetylator phenotypes with a role in the development of head and neck cancers (HNCs). Herein, we aimed to evaluate the association of NAT1 and NAT2 polymorphisms with susceptibility to HNCs in an updated meta-analysis. Materials and methods: A search was comprehensively performed in four databases (Web of Science, Scopus, PubMed/Medline, and Cochrane Library until 8 July 2021). The effect sizes, odds ratio (OR) along with 95% confidence interval (CI) were computed. Trial sequential analysis (TSA), publication bias and sensitivity analysis were conducted. Results: Twenty-eight articles including eight studies reporting NAT1 polymorphism and twenty-five studies reporting NAT2 polymorphism were involved in the meta-analysis. The results showed that individuals with slow acetylators of NAT2 polymorphism are at higher risk for HNC OR: 1.22 (95% CI: 1.02, 1.46; p = 0.03). On subgroup analysis, ethnicity, control source, and genotyping methods were found to be significant factors in the association of NAT2 polymorphism with the HNC risk. TSA identified that the amount of information was not large enough and that more studies are needed to establish associations. Conclusions: Slow acetylators in NAT2 polymorphism were related to a high risk of HNC. However, there was no relationship between NAT1 polymorphism and the risk of HNC.
Open AccessAssociation of N-acetyltransferases 1 and 2 Polymorphisms with Susceptibility to Head and Neck Cancers—A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis
Background and objective:N-acetyltransferases 1 and 2 (NAT1 and NAT2) genes have polymorphisms in accordance with slow and rapid acetylator phenotypes with a role in the development of head and neck cancers (HNCs). Herein, we aimed to evaluate the association of NAT1 and NAT2 polymorphisms with susceptibility to HNCs in an updated meta-analysis. Materials and methods: A search was comprehensively performed in four databases (Web of Science, Scopus, PubMed/Medline, and Cochrane Library until 8 July 2021). The effect sizes, odds ratio (OR) along with 95% confidence interval (CI) were computed. Trial sequential analysis (TSA), publication bias and sensitivity analysis were conducted. Results: Twenty-eight articles including eight studies reporting NAT1 polymorphism and twenty-five studies reporting NAT2 polymorphism were involved in the meta-analysis. The results showed that individuals with slow acetylators of NAT2 polymorphism are at higher risk for HNC OR: 1.22 (95% CI: 1.02, 1.46; p = 0.03). On subgroup analysis, ethnicity, control source, and genotyping methods were found to be significant factors in the association of NAT2 polymorphism with the HNC risk. TSA identified that the amount of information was not large enough and that more studies are needed to establish associations. Conclusions: Slow acetylators in NAT2 polymorphism were related to a high risk of HNC. However, there was no relationship between NAT1 polymorphism and the risk of HNC.